Q1 2022 13F Holders as of 31 Mar 2022
-
Type / Class
-
Equity / Common Stock, $0.0001 par value per share
-
Shares outstanding
-
45,101,565
-
Total 13F shares
-
21,920,374
-
Share change
-
-585,958
-
Total reported value
-
$260,413,152
-
Price per share
-
$11.88
-
Number of holders
-
83
-
Value change
-
-$16,642,002
-
Number of buys
-
38
-
Number of sells
-
48
Institutional Holders of Y-mAbs Therapeutics, Inc. - Common Stock, $0.0001 par value per share (YMAB) as of Q1 2022
As of 31 Mar 2022 Y-mAbs Therapeutics, Inc. - Common Stock, $0.0001 par value per share (YMAB) had 83 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 21,920,374 shares of stock of the company.
Largest 10 holders included ALLIANCEBERNSTEIN L.P., Polar Capital Holdings Plc, STATE STREET CORP, Sofinnova Investments, Inc., FMR LLC, WELLINGTON MANAGEMENT GROUP LLP, VANGUARD GROUP INC, GEODE CAPITAL MANAGEMENT, LLC, MORGAN STANLEY, and BIOIMPACT CAPITAL LLC.
This table shows 84 institutional shareholders of the security as of 31 Mar 2022.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.